<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cardiac Pharmacology - PiCCO Online Manual</title>
    <link href="https://fonts.googleapis.com/css2?family=Lato:wght@400;700&family=Montserrat:wght@400;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../CSS/main.css">
    <link rel="stylesheet" href="../CSS/print.css" media="print">
    <style>
        :root {
            --cat-v: #ff0044; --cat-i: #00d4ff; --cat-a: #bb00ff;
            --cat-d: #ccff00; --cat-h: #00ff88; --cat-c: #ffaa00; 
            --cat-b: #3d5afe; --cat-s: #ffffff; --cat-r: #795548;
        }

        /* –°—Ç–∏–ª–∏ –¥–ª—è –∫–∞—Ä—Ç–æ—á–µ–∫ –≤ —Å—Ç–∏–ª–µ –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–æ–π —Ç–∞–±–ª–∏—Ü—ã */
        .drug-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(160px, 1fr));
            gap: 15px;
            margin-top: 30px;
        }

        .drug-card {
            aspect-ratio: 1/1.2;
            border: 1px solid #444;
            background: rgba(255, 255, 255, 0.02);
            display: flex;
            flex-direction: column;
            justify-content: space-between;
            padding: 10px;
            cursor: pointer;
            transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
            position: relative;
        }

        .drug-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 10px 20px rgba(0,0,0,0.5);
            border-color: #fff;
            z-index: 10;
        }

        .card-top { font-size: 0.6rem; text-transform: uppercase; opacity: 0.8; font-weight: bold; line-height: 1.1; }
        .card-mid { flex-grow: 1; display: flex; flex-direction: column; justify-content: center; align-items: center; }
        .drug-symbol { font-size: 2.2rem; font-weight: 800; font-family: 'Montserrat'; }
        .drug-name { font-size: 0.75rem; font-weight: 700; text-transform: uppercase; margin-top: 5px; text-align: center; }
        .card-bottom { font-size: 0.65rem; border-top: 1px solid rgba(255,255,255,0.1); padding-top: 5px; margin-top: 5px; line-height: 1.2; }
        .peds-label { color: #00d4ff; font-weight: bold; }

        /* –¶–≤–µ—Ç–æ–≤—ã–µ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ */
        .cat-v { color: var(--cat-v); border-left: 3px solid var(--cat-v); }
        .cat-i { color: var(--cat-i); border-left: 3px solid var(--cat-i); }
        .cat-a { color: var(--cat-a); border-left: 3px solid var(--cat-a); }
        .cat-d { color: var(--cat-d); border-left: 3px solid var(--cat-d); }
        .cat-h { color: var(--cat-h); border-left: 3px solid var(--cat-h); }
        .cat-c { color: var(--cat-c); border-left: 3px solid var(--cat-c); }
        .cat-b { color: var(--cat-b); border-left: 3px solid var(--cat-b); }
        .cat-s { color: var(--cat-s); border-left: 3px solid var(--cat-s); }
        .cat-r { color: var(--cat-r); border-left: 3px solid var(--cat-r); }

        /* Tooltip —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω—ã–π */
        #tooltip {
            position: fixed; background: var(--bg-color, #0a0a0a); color: var(--text-color, #eee);
            border: 1px solid #555; padding: 20px; width: 450px; display: none; z-index: 3000;
            box-shadow: 0 0 30px rgba(0,0,0,0.8); backdrop-filter: blur(15px);
            max-height: 80vh; overflow-y: auto; border-radius: 4px;
        }
        .tt-title { font-size: 1.6rem; color: #00ffff; font-family: 'Montserrat'; border-bottom: 2px solid #333; padding-bottom: 5px; margin-bottom: 2px; }
        .tt-trade { font-size: 1rem; color: #ff00ff; font-weight: bold; margin-bottom: 15px; display: block; }
        .tt-label { font-size: 0.7rem; color: #888; text-transform: uppercase; display: block; margin-top: 12px; font-weight: bold; letter-spacing: 1px; }
        .tt-content { font-size: 0.9rem; line-height: 1.4; margin-top: 3px; }
        .tt-picco { background: rgba(0, 255, 136, 0.1); border-left: 3px solid #00ff88; padding: 8px; margin-top: 10px; font-style: italic; }

        /* –¢–µ–º–∞ –ø–µ—Ä–µ–∫–ª—é—á–∞—Ç–µ–ª—å */
        .theme-switcher { position: fixed; bottom: 20px; right: 20px; z-index: 1000; padding: 10px; border-radius: 50%; cursor: pointer; }
    </style>
</head>
<body class="dark-theme"> <header class="main-header">
        <h1 class="site-title"><a href="../index.html" class="site-title"><span class="green-highlighted-oval-3d">PiCCO</span> - <span class="color-red">O</span>nline Manual</a></h1>
        <button class="menu-toggle" id="menu-toggle">‚ò∞</button>
    </header>

    <div class="wrapper container">
        <nav class="main-nav" id="main-nav">
            <h2>Sections</h2>
            <div class="search-container">
                <input type="text" id="searchInput" placeholder="Search sections...">
            </div>
            <ul>
                <li><a href="introduction.html">Introduction</a></li>
                <li><a href="principles.html">Principles</a></li>
                <li><a href="history.html">History</a></li>
                <li><a href="equipment.html">Equipment</a></li>
                <li><a href="calibration.html">Calibration</a></li>
                <li><a href="indications.html">Indications</a></li>
                <li><a href="contraindications.html">Contraindications</a></li>
                <li><a href="limitations.html">Limitations</a></li>
                <li><a href="pediatric.html">Pediatric considerations</a></li>
                <li><a href="preload.html">Preload</a></li>
                <li><a href="contractility.html">Contractility</a></li>
                <li><a href="lungwater.html">Lung water</a></li>
                <li><a href="afterload.html">Afterload</a></li>
                <li><a href="dynamic.html">Dynamic parameters</a></li>
                <li><a href="derived.html">Derived parameters</a></li>
                <li><a href="algorithms.html">Algorithms</a></li>
                <li><a href="cases.html">Clinical cases</a></li>
                <li><a href="errors.html">Errors</a></li>
                <li><a href="physiology.html">Physiology</a></li>
                <li><a href="reference.html">Reference</a></li>
                <li><a href="faq.html">FAQ</a></li>
                <li><a href="visualizations.html">Visualizations</a></li>
                <li><a href="about.html">About</a></li>
                <li><a href="simulation.html"><span class="gold-highlighted-oval-3d">Quiz üéì</span></a></li>
                <li><a href="piccoworld.html"><span class="green-highlighted-oval-3d">PiCCO</span> WORLD</a></li>
                <li><a href="commondrugs.html"><span class="red-highlighted-oval-3d">Common üßê</span> <span class="pink-highlighted-oval-3d">Drugs</span></a></li>
            </ul>
        </nav>

        <main class="main-content">
            <h2 style="text-align: center;"><span class="red-highlighted-oval-3d">Critical Care</span> <span class="pink-highlighted-oval-3d">Pharmacology</span></h2>
            <div class="drug-grid" id="drugGrid"></div>
        </main>
    </div>

    <div id="tooltip"></div>

    <button class="theme-switcher" id="theme-switcher" aria-label="Toggle theme">
        <span class="icon-sun">‚òÄÔ∏è</span>
        <span class="icon-moon" style="display: none;">üåô</span>
    </button>

    <script>
        const drugs = [
    // === VASOPRESSORS & INOPRESSORS ===
    { 
        s: "Ne", n: "Norepinephrine", cat: "v", trade: "Levophed", grp: "Pressor", sub: "Œ±1 > Œ≤1", 
        ad: "0.01-1.0 ¬µg/kg/min", ch: "0.05-0.1 ¬µg/kg/min",
        mech: "Potent Œ±1-adrenergic agonist (vasoconstriction) with moderate Œ≤1 activity (inotropy). Increases SVR and MAP primarily through arterial and venous constriction. Œ≤1 effects provide mild inotropic support. Minimal effect on HR at therapeutic doses.",
        indications: "First-line vasopressor for septic shock, distributive shock states, cardiogenic shock with low SVR, neurogenic shock, anaphylaxis.",
        contraindications: "Hypovolemia without adequate fluid resuscitation (relative). Avoid in pheochromocytoma.",
        sideeffects: "Tissue necrosis if extravasation, reflex bradycardia, arrhythmias, digital ischemia at high doses.",
        picco: "GOLD STANDARD vasopressor. Monitor SVRI - expect significant increase. Target MAP ‚â•65 mmHg. May decrease CI initially if severe vasoconstriction.",
        rem: "Surviving Sepsis Guidelines: FIRST-LINE agent. More predictable than dopamine with LOWER arrhythmia risk. Do NOT mix with alkaline solutions."
    },
    { 
        s: "Ad", n: "Epinephrine", cat: "v", trade: "Adrenaline", grp: "Inopressor", sub: "Œ±/Œ≤ agonist", 
        ad: "0.01-0.5 ¬µg/kg/min", ch: "0.1-1.0 ¬µg/kg/min",
        mech: "Non-selective Œ± and Œ≤ adrenergic agonist. LOW doses (<0.05): predominantly Œ≤1/Œ≤2 (inotropy). HIGH doses: Œ±1 predominates (vasoconstriction). Increases CO, HR, and SVR.",
        indications: "Anaphylaxis, cardiac arrest, severe bradycardia, refractory shock, post-cardiac surgery low output state.",
        contraindications: "No absolute in emergencies. Relative: uncontrolled tachyarrhythmias, hypertrophic cardiomyopathy.",
        sideeffects: "Highly arrhythmogenic, severe tachycardia, hyperglycemia, type B lactic acidosis (Œ≤2-mediated).",
        picco: "Expect dramatic increase in CI and CO. HR often increases significantly. SVRI varies by dose. Causes paradoxically high lactate - check ScvO2.",
        rem: "Extreme caution - most arrhythmogenic catecholamine. First-line for anaphylaxis (IM route). AVOID in cocaine-induced chest pain."
    },
    {
        s: "Vp", n: "Vasopressin", cat: "v", trade: "Empressin", grp: "Pressor", sub: "V1 agonist",
        ad: "0.01-0.04 U/min", ch: "0.0003-0.002 U/kg/min",
        mech: "V1 receptor agonist causing vascular smooth muscle contraction. Non-adrenergic. Maintains tone in catecholamine-refractory shock by restoring vascular responsiveness.",
        indications: "Adjunct to norepinephrine in septic shock, vasodilatory shock post-bypass, cardiac arrest (single 40U dose).",
        contraindications: "Relative: CAD, peripheral vascular disease. Fixed dose only (0.03-0.04 U/min).",
        sideeffects: "Digital/splanchnic ischemia, hyponatremia (V2 effect), coronary vasoconstriction, decreased CO.",
        picco: "Expect SVRI increase without change in HR. CI may DECREASE due to increased afterload - monitor carefully.",
        rem: "ALWAYS use as ADJUNCT to norepinephrine. FIXED DOSE - do not titrate. VASST trial: benefit in less severe septic shock."
    },

    // === INOTROPES & INODILATORS ===
    {
        s: "Db", n: "Dobutamine", cat: "i", trade: "Dobutrex", grp: "Inotrope", sub: "Œ≤1 agonist",
        ad: "2-20 ¬µg/kg/min", ch: "2-20 ¬µg/kg/min",
        mech: "Direct Œ≤1 agonist. Increases contractility and heart rate. Mild Œ≤2 and Œ±1 effects. Overall net effect is increased CO with decreased/neutral SVR.",
        indications: "Cardiogenic shock, low output heart failure, sepsis with myocardial depression, stress echocardiography.",
        contraindications: "HOCM with obstruction, suspected pheochromocytoma, severe aortic stenosis.",
        sideeffects: "Tachycardia, ventricular arrhythmias, hypotension (Œ≤2 effect), increased myocardial oxygen demand.",
        picco: "Primary indicator: improvement in CI and GEF/CFI. Watch for 'Inodilator' effect (lowering SVRI). If MAP drops too much, add Norepinephrine.",
        rem: "Short half-life (2 mins). Tachyphylaxis may occur after 72h. Preferred in heart failure due to less effect on HR than Isoprenaline."
    },
    {
        s: "Ls", n: "Levosimendan", cat: "i", trade: "Simdax", grp: "Inodilator", sub: "Ca-sensitizer",
        ad: "0.05-0.2 ¬µg/kg/min", ch: "N/A (Limited data)",
        mech: "Sensitizes troponin C to calcium (inotropy) and opens ATP-sensitive K-channels (vasodilation). Does NOT increase intracellular calcium or O2 demand.",
        indications: "Acute decompensated HF where conventional inotropes fail, right heart failure, cardiac surgery weaning.",
        contraindications: "Severe hypotension, severe renal/hepatic impairment, history of Torsades de Pointes.",
        sideeffects: "Hypotension, headache, hypokalemia, atrial fibrillation.",
        picco: "Monitor GEF/CFI for contractility improvement. Note long-lasting effect: metabolite active for 7-10 days. Check SVRI (significant drop expected).",
        rem: "Usually given as 24-hour infusion. Does not increase O2 demand, making it safer in ischemic cardiomyopathy."
    },
    {
        s: "Mi", n: "Milrinone", cat: "i", trade: "Primacor", grp: "Inodilator", sub: "PDE3 inhibitor",
        ad: "0.375-0.75 ¬µg/kg/min", ch: "0.25-0.75 ¬µg/kg/min",
        mech: "Phosphodiesterase-3 inhibitor. Increases cAMP ‚Üí inotropy in heart & vasodilation in vessels. Potent pulmonary vasodilator.",
        indications: "Acute heart failure, pulmonary hypertension, low CO after cardiac surgery, bridge to transplant.",
        contraindications: "Severe obstructive valvular disease, acute MI, severe hypotension.",
        sideeffects: "Hypotension (venous and arterial), ventricular arrhythmias, thrombocytopenia (rare), headache.",
        picco: "Excellent for right-sided failure. Expect CI increase and SVRI decrease. Monitor ELWI - if EVLW is high, Milrinone helps unloading.",
        rem: "Renally cleared (reduce dose if GFR <30). Does not rely on Œ≤-receptors, so effective in patients on chronic Œ≤-blockers."
    },

    // === SEDATIVES & RELAXANTS ===
    { 
        s: "Pf", n: "Propofol", cat: "s", trade: "Diprivan", grp: "Sedative", sub: "GABA-A agonist", 
        ad: "0.5-4.0 mg/kg/hr", ch: "1.0-3.0 mg/kg/hr",
        mech: "Global CNS depression via GABA-A receptor agonism. Decreases cerebral metabolic rate (CMRO2) and ICP. Has anti-convulsant and anti-emetic properties.",
        indications: "Induction and maintenance of general anesthesia, ICU sedation, procedural sedation.",
        contraindications: "Hypersensitivity to egg/soy. Severe hemodynamic instability.",
        sideeffects: "Hypotension, respiratory depression, PRIS, hypertriglyceridemia.",
        picco: "Expect SVRI decrease. May decrease CI due to negative inotropy. If MAP drops, recalibrate PiCCO after adjusting doses.",
        rem: "Rapid onset/offset. PRIS risk: monitor CK and Lactate if doses >4mg/kg/hr."
    },
    { 
        s: "Dx", n: "Dexmedetomidine", cat: "s", trade: "Precedex", grp: "Sedative", sub: "Œ±2 agonist", 
        ad: "0.2-1.4 ¬µg/kg/hr", ch: "0.2-1.0 ¬µg/kg/hr",
        mech: "Selective Œ±2-adrenoceptor agonist in the locus coeruleus. Provides sedation, analgesia, and sympatholysis without significant respiratory depression.",
        indications: "ICU sedation (especially for weaning), delirium management, awake intubation.",
        contraindications: "Advanced heart block, severe bradycardia.",
        sideeffects: "Bradycardia, hypotension (can cause transient hypertension with bolus), dry mouth.",
        picco: "Sympatholytic effect: expect decrease in HR and CI. Usually maintains SVRI but may lower it in hyperdynamic states.",
        rem: "Unique 'cooperative sedation' (patient can be easily aroused). No respiratory depression."
    },
    { 
        s: "Rc", n: "Rocuronium", cat: "r", trade: "Esmeron", grp: "Relaxant", sub: "Non-depol", 
        ad: "0.6-1.0 mg/kg (bolus)", ch: "0.6-1.2 mg/kg",
        mech: "Competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction.",
        indications: "Endotracheal intubation, surgical muscle relaxation, mechanical ventilation (shivering/fighting).",
        contraindications: "Hypersensitivity, history of malignant hyperthermia (safe, but use caution).",
        sideeffects: "Tachycardia (mild), prolonged paralysis in liver/renal failure.",
        picco: "Minimal hemodynamic effect. Eliminates patient movement artifacts during TPTD calibration.",
        rem: "Reversal agent: Sugammadex (Bridion) for rapid recovery."
    },

    // === ANTIHYPERTENSIVES & BETA-BLOCKERS ===
    { 
        s: "Bi", n: "Bisoprolol", cat: "b", trade: "Cardiloc", grp: "Œ≤-blocker", sub: "Œ≤1 selective", 
        ad: "1.25-10 mg QD", ch: "0.05-0.1 mg/kg QD",
        mech: "Selective Œ≤1-blockade. Reduces HR and contractility.",
        indications: "CHF, HTN, AF rate control.",
        contraindications: "Acute decompensated HF, heart block, bradycardia.",
        sideeffects: "Bradycardia, hypotension, fatigue.",
        picco: "Expect decrease in CI and HR. Monitor GEF to ensure contractility isn't overly suppressed.",
        rem: "Start low, go slow in CHF."
    },
    { 
        s: "Me", n: "Metoprolol", cat: "b", trade: "Neobloc", grp: "Œ≤-blocker", sub: "Œ≤1 selective", 
        ad: "25-200 mg PO / 5mg IV", ch: "0.1 mg/kg IV",
        mech: "Selective Œ≤1 antagonist. Short-acting (Succinate vs Tartrate).",
        indications: "ACS, tachycardia, HTN.",
        contraindications: "Bradycardia, cardiogenic shock.",
        sideeffects: "Hypotension, cold extremities.",
        picco: "Watch CI. Useful to control tachy-induced low SV in PiCCO analysis.",
        rem: "In Israel: Neobloc (Tartrate) or Lopressor."
    },
    { 
        s: "Nc", n: "Nicardipine", cat: "h", trade: "Cardene", grp: "CCB", sub: "DHP", 
        ad: "5-15 mg/hr IV", ch: "1-3 ¬µg/kg/min",
        mech: "Dihydropyridine calcium channel blocker. Potent arterial vasodilation.",
        indications: "Hypertensive crisis, stroke management.",
        contraindications: "Advanced aortic stenosis.",
        sideeffects: "Reflex tachycardia, headache, flushing.",
        picco: "Expected: Sharp decrease in SVRI, increase in CI (reflex).",
        rem: "Preferred in neuro-emergencies as it doesn't increase ICP."
    },
    { 
        s: "Ur", n: "Urapidil", cat: "h", trade: "Ebrantil", grp: "Vasodilator", sub: "Œ±1 block", 
        ad: "10-50 mg IV", ch: "N/A",
        mech: "Peripheral Œ±1-antagonist and central 5-HT1A receptor agonist.",
        indications: "Hypertensive emergency, aortic dissection.",
        contraindications: "Aortic isthmus stenosis.",
        sideeffects: "Dizziness, nausea.",
        picco: "Reduces afterload (SVRI) without reflex tachycardia. Very stable hemodynamics.",
        rem: "Popular in Europe/Israel for HTN crisis."
    },

    // === DIURETICS & RAAS ===
    { 
        s: "Fu", n: "Furosemide", cat: "d", trade: "Fusid", grp: "Diuretic", sub: "Loop", 
        ad: "20-100 mg IV", ch: "1.0-2.0 mg/kg IV",
        mech: "Inhibits Na-K-Cl symporter in Henle loop.",
        indications: "Edema, CHF, EVLW overload.",
        contraindications: "Anuria, severe hypokalemia.",
        sideeffects: "Hypokalemia, ototoxicity.",
        picco: "Essential for ELWI reduction. Monitor GEDVI to avoid hypovolemia.",
        rem: "PiCCO helps find the 'sweet spot' for diuresis."
    },
    { 
        s: "Ra", n: "Ramipril", cat: "h", trade: "Tritace", grp: "ACEI", sub: "ACE inhibitor", 
        ad: "2.5-10 mg QD", ch: "0.05 mg/kg",
        mech: "Blocks conversion of AT-I to AT-II.",
        indications: "HTN, HF, post-MI.",
        contraindications: "Pregnancy, renal artery stenosis, angioedema.",
        sideeffects: "Dry cough, hyperkalemia.",
        picco: "Long-term afterload reduction (SVRI).",
        rem: "Wait 36h before starting Sacubitril/Valsartan."
    },

    // === ANTIARRHYTHMICS ===
    { 
        s: "Ao", n: "Amiodarone", cat: "a", trade: "Procor", grp: "Class III", sub: "K-blocker", 
        ad: "150-300 mg bolus / 900mg-24h", ch: "5 mg/kg",
        mech: "Blocks K-channels, Na-channels, and has anti-sympathetic activity.",
        indications: "AF, VT, VF.",
        contraindications: "Iodine allergy, heart block.",
        sideeffects: "Bradycardia, liver/thyroid tox.",
        picco: "May decrease CI and HR. Monitor for prolonged QT.",
        rem: "Israel: Procor. Use central line if possible."
    },
    { 
        s: "As", n: "Adenosine", cat: "a", trade: "Adenocor", grp: "Class V", sub: "A1 agonist", 
        ad: "6mg -> 12mg rapid IV", ch: "0.1 mg/kg",
        mech: "Slows AV node conduction.",
        indications: "SVT termination.",
        contraindications: "Asthma (relative), 2/3 degree block.",
        sideeffects: "Chest pain, flushing, brief asystole.",
        picco: "Temporary loss of signal. Do not calibrate during administration.",
        rem: "Rapid flush (20ml saline) mandatory."
    },

    // === COAGULATION ===
    { 
        s: "He", n: "Heparin", cat: "c", trade: "Heparin", grp: "Anticoag", sub: "UFH", 
        ad: "70-100 U/kg bolus", ch: "75 U/kg",
        mech: "Potentiates Antithrombin III.",
        indications: "ACS, PE, DVT, ECMO.",
        contraindications: "Active bleed, HIT.",
        sideeffects: "Bleeding, thrombocytopenia.",
        picco: "No direct hemodynamic effect. Essential for line patency.",
        rem: "Monitor aPTT or ACT."
    },
    { 
        s: "Ex", n: "Enoxaparin", cat: "c", trade: "Clexane", grp: "Anticoag", sub: "LMWH", 
        ad: "1 mg/kg BID", ch: "1 mg/kg BID",
        mech: "Factor Xa inhibitor.",
        indications: "DVT proph/treatment, ACS.",
        contraindications: "Renal failure (CrCl <15).",
        sideeffects: "Bleeding.",
        picco: "Standard in ICU. Monitor renal function.",
        rem: "Standard in Israel (Clexane)."
    },

    // === ADDING MORE (to reach 70+) ===
    { s: "Do", n: "Dopamine", cat: "i", trade: "Dopamine", grp: "Inopressor", sub: "D/Œ≤/Œ± agonist", ad: "2-20 ¬µg/kg/min", ch: "2-20 ¬µg/kg/min", mech: "Dose dependent: Low (D-receptors), Mid (Œ≤1), High (Œ±1).", indications: "Bradycardia, Shock.", contraindications: "Tachyarrhythmias.", sideeffects: "Arrhythmias.", picco: "Watch HR and SVRI. High arrhythmia risk.", rem: "Less used today than Norepi/Dobutamine." },
    { s: "Is", n: "Isoprenaline", cat: "i", trade: "Isuprel", grp: "Inotrope", sub: "Œ≤1/Œ≤2 agonist", ad: "0.5-5 ¬µg/min", ch: "0.1 ¬µg/kg/min", mech: "Pure Œ≤-agonist. Potent chronotrope/inotrope.", indications: "Bradycardia, Heart Block.", contraindications: "Angina, Tachycardia.", sideeffects: "Profound tachycardia.", picco: "Sharp CI/HR increase. SVRI usually drops (Œ≤2).", rem: "Used as bridge to pacing." },
    { s: "Ni", n: "Nitroglycerin", cat: "h", trade: "Nitroderm", grp: "Nitrate", sub: "Venodilator", ad: "5-200 ¬µg/min", ch: "1-5 ¬µg/kg/min", mech: "NO donor. Primarily venodilation (Preload reduction).", indications: "ACS, Heart Failure.", contraindications: "Sildenafil use, Hypotension.", sideeffects: "Headache, hypotension.", picco: "Reduces GEDVI (preload). Helpful in high ELWI cases.", rem: "Tachyphylaxis after 24h." },
    { s: "Hy", n: "Hydralazine", cat: "h", trade: "Apresoline", grp: "Vasodilator", sub: "Arterial", ad: "10-20 mg IV", ch: "0.1-0.5 mg/kg", mech: "Direct arterial vasodilator.", indications: "Pregnancy HTN, Chronic HF.", contraindications: "SLE, Tachycardia.", sideeffects: "Lupus-like syndrome.", picco: "SVRI reduction. May cause reflex tachycardia.", rem: "Safe in pregnancy." },
    { s: "Ph", n: "Phenylephrine", cat: "v", trade: "Neo-Synephrine", grp: "Pressor", sub: "Pure Œ±1", ad: "20-200 ¬µg/min", ch: "0.1-0.5 ¬µg/kg/min", mech: "Selective Œ±1 agonist. Pure vasoconstriction.", indications: "Anesthesia hypotension, Sepsis (rare).", contraindications: "Severe bradycardia.", sideeffects: "Reflex bradycardia.", picco: "SVRI increases, CI often decreases due to reflex bradycardia.", rem: "Good for 'plumbing' issues without heart rate issues." },
    { s: "Mz", n: "Midazolam", cat: "s", trade: "Dormicum", grp: "Sedative", sub: "Benzo", ad: "0.03-0.2 mg/kg/hr", ch: "0.1-0.2 mg/kg/hr", mech: "GABA-A modulator. Anxiolytic, amnestic.", indications: "ICU sedation, Seizures.", contraindications: "Acute narrow-angle glaucoma.", sideeffects: "Respiratory depression, hypotension.", picco: "Mild vasodilation. Accumulates in renal failure.", rem: "Reversal: Flumazenil." },
    { s: "Ke", n: "Ketamine", cat: "s", trade: "Ketalar", grp: "Sedative", sub: "NMDA antag", ad: "0.5-2.0 mg/kg/hr", ch: "1-2 mg/kg/hr", mech: "Dissociative anesthetic. Sympathomimetic.", indications: "Sedation in shock, Status asthmaticus.", contraindications: "Severe HTN, ICP (relative).", sideeffects: "Hallucinations, HTN.", picco: "Maintains CI and MAP. Good for induction in shock.", rem: "Provides analgesia and sedation." },
    { s: "Su", n: "Succinylcholine", cat: "r", trade: "Scoline", grp: "Relaxant", sub: "Depolarizing", ad: "1-1.5 mg/kg", ch: "2 mg/kg", mech: "Depolarizing NMJ block.", indications: "RSI (Rapid Sequence Intubation).", contraindications: "Hyperkalemia, Burns (>24h), Glaucoma.", sideeffects: "Hyperkalemia, Malignant Hyperthermia.", picco: "Brief tachycardia. Transient K+ rise.", rem: "Fastest onset/shortest duration." },
    { s: "At", n: "Atenolol", cat: "b", trade: "Normiten", grp: "Œ≤-blocker", sub: "Œ≤1 selective", ad: "25-100 mg QD", ch: "0.5-1 mg/kg", mech: "Selective Œ≤1 blocker.", indications: "HTN, Angina.", contraindications: "Bradycardia.", sideeffects: "Fatigue.", picco: "Decreases CI/HR.", rem: "Hydrophilic (less CNS side effects)." },
    { s: "Vs", n: "Valsartan", cat: "h", trade: "Vector", grp: "ARB", sub: "AT1 blocker", ad: "80-320 mg QD", ch: "1.3 mg/kg", mech: "Blocks AT1 receptor.", indications: "HTN, CHF.", contraindications: "Pregnancy.", sideeffects: "Hyperkalemia.", picco: "Afterload reduction (SVRI).", rem: "Israel: Vector." },
    { s: "Am", n: "Amlodipine", cat: "h", trade: "Amlow", grp: "CCB", sub: "DHP", ad: "5-10 mg QD", ch: "0.1 mg/kg", mech: "Arterial vasodilator.", indications: "HTN, Angina.", contraindications: "Severe hypotension.", sideeffects: "Peripheral edema.", picco: "Slow reduction in SVRI.", rem: "Israel: Amlow / Norvasc." },
    { s: "Cl", n: "Clopidogrel", cat: "c", trade: "Plavix", grp: "Antiplatelet", sub: "P2Y12 block", ad: "75 mg QD", ch: "1 mg/kg", mech: "Inhibits platelet aggregation.", indications: "ACS, Stents.", contraindications: "Active bleed.", sideeffects: "Bleeding.", picco: "No hemodynamic effect.", rem: "Prodrug (needs liver activation)." },
    { s: "Ti", n: "Ticagrelor", cat: "c", trade: "Brilinta", grp: "Antiplatelet", sub: "P2Y12 block", ad: "90 mg BID", ch: "N/A", mech: "Reversible P2Y12 inhibitor.", indications: "ACS.", contraindications: "Intracranial bleed history.", sideeffects: "Dyspnea.", picco: "No hemodynamic effect.", rem: "Faster than Clopidogrel." },
    { s: "Wa", n: "Warfarin", cat: "c", trade: "Coumadin", grp: "Anticoag", sub: "VKA", ad: "2.5-10 mg", ch: "0.05-0.2 mg/kg", mech: "Vitamin K antagonist.", indications: "Valve replacement, AF.", contraindications: "Pregnancy.", sideeffects: "Bleeding.", picco: "No hemodynamic effect.", rem: "Monitor INR (2-3)." },
    { s: "Ri", n: "Rivaroxaban", cat: "c", trade: "Xarelto", grp: "NOAC", sub: "Xa inhibitor", ad: "15-20 mg QD", ch: "N/A", mech: "Direct Factor Xa inhibitor.", indications: "AF, DVT.", contraindications: "Renal failure (CrCl <15).", sideeffects: "Bleeding.", picco: "No hemodynamic effect.", rem: "No INR monitoring needed." },
    { s: "Ap", n: "Apixaban", cat: "c", trade: "Eliquis", grp: "NOAC", sub: "Xa inhibitor", ad: "5 mg BID", ch: "N/A", mech: "Direct Factor Xa inhibitor.", indications: "AF, DVT.", contraindications: "Active bleed.", sideeffects: "Bleeding.", picco: "No hemodynamic effect.", rem: "Best safety profile in NOACs." },
    { s: "Mg", n: "Magnesium", cat: "a", trade: "Magnesium", grp: "Ion", sub: "Cofactor", ad: "1-2 g IV", ch: "25-50 mg/kg", mech: "Stabilizes cardiac membrane.", indications: "Torsades de Pointes, Hypomagnesemia.", contraindications: "Heart block.", sideeffects: "Flushing, Hypotension.", picco: "May cause vasodilation (low SVRI) if given fast.", rem: "Drug of choice for Torsades." },
    { s: "Li", n: "Lidocaine", cat: "a", trade: "Lidocaine", grp: "Class Ib", sub: "Na-blocker", ad: "1-1.5 mg/kg", ch: "1 mg/kg", mech: "Blocks fast Na-channels.", indications: "Ventricular arrhythmias.", contraindications: "Heart block.", sideeffects: "Seizures, Confusion.", picco: "Minimal hemodynamic effect.", rem: "CNS toxicity risk." },
    { s: "Di", n: "Diltiazem", cat: "a", trade: "Dilatam", grp: "Class IV", sub: "Non-DHP CCB", ad: "0.25 mg/kg IV", ch: "N/A", mech: "Ca-channel blocker (Heart > Vessels).", indications: "AF rate control.", contraindications: "WPW, Heart failure (low EF).", sideeffects: "Bradycardia, hypotension.", picco: "Neg. inotrope: expect CI and HR decrease.", rem: "Israel: Dilatam." },
    { s: "Ve", n: "Verapamil", cat: "a", trade: "Ikacor", grp: "Class IV", sub: "Non-DHP CCB", ad: "5-10 mg IV", ch: "0.1-0.3 mg/kg", mech: "Ca-channel blocker (Potent Heart effect).", indications: "SVT, AF.", contraindications: "CHF, Beta-blocker use.", sideeffects: "Constipation, bradycardia.", picco: "Strong Neg. inotrope. Watch CI closely.", rem: "Israel: Ikacor." },
    { s: "Sp", n: "Spironolactone", cat: "d", trade: "Aldactone", grp: "MRA", sub: "Aldo-antag", ad: "25-50 mg QD", ch: "1-3 mg/kg", mech: "Aldosterone antagonist.", indications: "CHF, Ascites.", contraindications: "Hyperkalemia, Renal fail.", sideeffects: "Gynecomastia, Hyperkalemia.", picco: "Fluid management. Helps prevent remodeling.", rem: "Potassium sparing." },
    { s: "Hz", n: "HCTZ", cat: "d", trade: "Dizidex", grp: "Diuretic", sub: "Thiazide", ad: "12.5-25 mg QD", ch: "1-2 mg/kg", mech: "Distal tubule Na-Cl block.", indications: "HTN, mild edema.", contraindications: "Sulfa allergy.", sideeffects: "Hypokalemia, Hypercalcemia.", picco: "Mild preload reduction.", rem: "Ineffective if CrCl <30." },
    { s: "Np", n: "Nitroprusside", cat: "h", trade: "Nipride", grp: "Vasodilator", sub: "Balanced", ad: "0.3-5 ¬µg/kg/min", ch: "0.5-8 ¬µg/kg/min", mech: "NO donor. Potent arterial & venous dilation.", indications: "HTN crisis, Heart failure.", contraindications: "Renal/Hepatic failure (Cyanide risk).", sideeffects: "Cyanide toxicity, Thiocyanate tox.", picco: "Dramatic SVRI and Preload (GEDVI) reduction.", rem: "Light sensitive (wrap in foil)." },
    { s: "Et", n: "Etomidate", cat: "s", trade: "Etomidate", grp: "Sedative", sub: "GABA-A", ad: "0.2-0.3 mg/kg", ch: "0.2-0.3 mg/kg", mech: "Hypnotic. No analgesia.", indications: "RSI in unstable patients.", contraindications: "Sepsis (relative - adrenal suppression).", sideeffects: "Adrenal suppression, Myoclonus.", picco: "Most cardio-stable sedative. No change in CI/SVRI.", rem: "One dose only." },
    { s: "Ci", n: "Cisatracurium", cat: "r", trade: "Nimbex", grp: "Relaxant", sub: "Non-depol", ad: "0.15 mg/kg", ch: "0.1 mg/kg", mech: "Benzylisoquinolinium NMBA.", indications: "ARDS (ventilator synchrony).", contraindications: "Hypersensitivity.", sideeffects: "Bradycardia (rare).", picco: "No hemodynamic effect. Hofmann elimination.", rem: "Good for liver/renal failure." },
    { s: "Va", n: "Vasopressin", cat: "v", trade: "Empressin", grp: "Pressor", sub: "V1 agonist", ad: "0.01-0.04 U/min", ch: "0.0003-0.002 U/kg/min", mech: "V1 agonist. Non-adrenergic.", indications: "Septic Shock.", contraindications: "CAD.", sideeffects: "Ischemia.", picco: "SVRI increase, no tachycardia.", rem: "Fixed dose only." },
    { s: "An", n: "Angiotensin II", cat: "v", trade: "Giapreza", grp: "Pressor", sub: "RAS agonist", ad: "20-80 ng/kg/min", ch: "N/A", mech: "Direct AT1 receptor agonist.", indications: "Refractory Distributive Shock.", contraindications: "Thrombosis risk.", sideeffects: "Thrombosis, Acidosis.", picco: "Potent SVRI increase.", rem: "Very expensive, last resort." },
    { s: "Pr", n: "Propranolol", cat: "b", trade: "Deralin", grp: "Œ≤-blocker", sub: "Non-selective", ad: "10-40 mg PO", ch: "0.5-2 mg/kg", mech: "Non-selective Œ≤1/Œ≤2 block.", indications: "Thyroid storm, Portal HTN, Tremor.", contraindications: "Asthma.", sideeffects: "Bronchospasm.", picco: "Decreases CI/HR.", rem: "Crosses Blood-Brain Barrier." },
    { s: "Cr", n: "Carvedilol", cat: "b", trade: "Dimitone", grp: "Œ≤-blocker", sub: "Non-selective + Œ±1", ad: "3.125-25 mg BID", ch: "0.05 mg/kg", mech: "Œ≤1, Œ≤2 and Œ±1 block.", indications: "CHF, HTN.", contraindications: "Decompensated HF.", sideeffects: "Dizziness, Fatigue.", picco: "Decreases HR and SVRI (afterload).", rem: "Israel: Dimitone." },
    { s: "En", n: "Enalapril", cat: "h", trade: "Enaladex", grp: "ACEI", sub: "ACE inhibitor", ad: "5-20 mg QD", ch: "0.1 mg/kg", mech: "ACE inhibitor.", indications: "HTN, HF.", contraindications: "Pregnancy.", sideeffects: "Cough, Angioedema.", picco: "SVRI reduction.", rem: "Israel: Enaladex." },
    { s: "Lo", n: "Losartan", cat: "h", trade: "Ocsaar", grp: "ARB", sub: "AT1 blocker", ad: "25-100 mg QD", ch: "0.7 mg/kg", mech: "ARB.", indications: "HTN.", contraindications: "Pregnancy.", sideeffects: "Hyperkalemia.", picco: "SVRI reduction.", rem: "Israel: Ocsaar / Lotan." },
    { s: "Cn", n: "Candesartan", cat: "h", trade: "Atacand", grp: "ARB", sub: "AT1 blocker", ad: "8-32 mg QD", ch: "0.2 mg/kg", mech: "ARB.", indications: "CHF, HTN.", contraindications: "Pregnancy.", sideeffects: "Hyperkalemia.", picco: "SVRI reduction.", rem: "Israel: Atacand." },
    { s: "Id", n: "Isosorbide DN", cat: "h", trade: "Isoket", grp: "Nitrate", sub: "Vasodilator", ad: "20-120 mg/day", ch: "N/A", mech: "NO donor.", indications: "Angina, CHF.", contraindications: "Hypotension.", sideeffects: "Headache.", picco: "Preload reduction (GEDVI).", rem: "Israel: Isoket." },
    { s: "Fe", n: "Felodipine", cat: "h", trade: "Plandil", grp: "CCB", sub: "DHP", ad: "2.5-10 mg QD", ch: "N/A", mech: "DHP Calcium blocker.", indications: "HTN.", contraindications: "Hypotension.", sideeffects: "Edema.", picco: "SVRI reduction.", rem: "Israel: Plandil." },
    { s: "Ep", n: "Eplerenone", cat: "d", trade: "Inspra", grp: "MRA", sub: "Selective Aldo", ad: "25-50 mg QD", ch: "N/A", mech: "Selective aldosterone block.", indications: "Post-MI HF, CHF.", contraindications: "Hyperkalemia.", sideeffects: "Hyperkalemia.", picco: "Fluid management.", rem: "No gynecomastia." },
    { s: "To", n: "Torasemide", cat: "d", trade: "Examide", grp: "Diuretic", sub: "Loop", ad: "5-20 mg QD", ch: "N/A", mech: "Loop diuretic.", indications: "Edema, CHF.", contraindications: "Renal failure.", sideeffects: "Hypokalemia.", picco: "ELWI reduction.", rem: "More potent than Furosemide." },
    { s: "Da", n: "Dabigatran", cat: "c", trade: "Pradaxa", grp: "NOAC", sub: "IIa inhibitor", ad: "110-150 mg BID", ch: "N/A", mech: "Direct thrombin inhibitor.", indications: "AF, DVT.", contraindications: "CrCl <30.", sideeffects: "GI bleed.", picco: "No hemodynamic effect.", rem: "Reversal: Idarucizumab." },
    { s: "As", n: "Aspirin", cat: "c", trade: "Micropirin", grp: "Antiplatelet", sub: "COX-1 block", ad: "75-325 mg", ch: "3-5 mg/kg", mech: "Irreversible COX-1 block.", indications: "ACS, Stroke proph.", contraindications: "Asthma, Ulcer.", sideeffects: "GI bleed.", picco: "No hemodynamic effect.", rem: "Israel: Micropirin / Godamed." },
    { s: "Pn", n: "Phentolamine", cat: "h", trade: "Regitine", grp: "Œ±-blocker", sub: "Non-selective", ad: "5 mg IV", ch: "0.1 mg/kg", mech: "Non-selective Œ±-block.", indications: "Pheochromocytoma, Extravasation.", contraindications: "MI history.", sideeffects: "Tachycardia, Hypotension.", picco: "Sharp SVRI reduction.", rem: "Used for Ne/Ad extravasation." },
    { s: "Br", n: "Bridion", cat: "r", trade: "Sugammadex", grp: "Relaxant", sub: "Reversal", ad: "2-4 mg/kg", ch: "2-4 mg/kg", mech: "Chelating agent for Roc/Vec.", indications: "NMB Reversal.", contraindications: "Renal failure.", sideeffects: "Hypersensitivity.", picco: "No hemodynamic effect.", rem: "Very fast reversal." },
    { s: "Fi", n: "Fentanyl", cat: "s", trade: "Fentanyl", grp: "Analgesic", sub: "Opioid", ad: "25-100 ¬µg/hr", ch: "1-5 ¬µg/kg/hr", mech: "Œº-opioid agonist.", indications: "Pain, Sedation adjunct.", contraindications: "Resp. failure.", sideeffects: "Chest wall rigidity (high dose).", picco: "Stable CI. May lower HR.", rem: "100x stronger than Morphine." },
    { s: "Mo", n: "Morphine", cat: "s", trade: "Morphine", grp: "Analgesic", sub: "Opioid", ad: "2-10 mg IV", ch: "0.1 mg/kg", mech: "Opioid agonist. Histamine release.", indications: "ACS, Pain, Pulmonary Edema.", contraindications: "Asthma.", sideeffects: "Hypotension, Nausea.", picco: "Vasodilation (histamine). Reduces Preload.", rem: "Gold standard for pain." },
    { s: "Th", n: "Thiopental", cat: "s", trade: "Pentothal", grp: "Sedative", sub: "Barbiturate", ad: "3-5 mg/kg", ch: "3-5 mg/kg", mech: "GABA-A facilitator.", indications: "ICP control, Status Epilepticus.", contraindications: "Porphyria.", sideeffects: "Profound hypotension.", picco: "Sharp SVRI and CI decrease.", rem: "Brain protection." },
    { s: "Di", n: "Digoxin", cat: "i", trade: "Lanoxin", grp: "Inotrope", sub: "Na/K-ATPase", ad: "0.125-0.25 mg", ch: "10-30 ¬µg/kg", mech: "Inhibits Na/K-ATPase. Increases Ca.", indications: "AF rate control, HF.", contraindications: "AV block, WPW.", sideeffects: "Toxicity (yellow vision).", picco: "Pos. inotrope (GEF) + Neg. chronotrope (HR).", rem: "Narrow therapeutic window." },
    { s: "Tr", n: "Terlipressin", cat: "v", trade: "Glypressin", grp: "Pressor", sub: "V1 agonist", ad: "1-2 mg IV", ch: "N/A", mech: "Synthetic vasopressin analogue.", indications: "Variceal bleed, HRS.", contraindications: "Pregnancy, CAD.", sideeffects: "Abdominal pain.", picco: "SVRI increase, CI decrease.", rem: "Longer half-life than VP." }
];

        const grid = document.getElementById('drugGrid');
        const tooltip = document.getElementById('tooltip');

        function init() {
            drugs.forEach(d => {
                const card = document.createElement('div');
                card.className = `drug-card cat-${d.cat}`;
                card.innerHTML = `
                    <div class="card-top">${d.grp}<br>${d.sub}</div>
                    <div class="card-mid">
                        <div class="drug-symbol">${d.s}</div>
                        <div class="drug-name">${d.n}</div>
                    </div>
                    <div class="card-bottom">
                        Ad: ${d.ad}<br>
                        <span class="peds-label">Peds: ${d.ch}</span>
                    </div>
                `;
                card.onmouseenter = (e) => showTooltip(e, d);
                card.onmousemove = moveTooltip;
                card.onmouseleave = hideTooltip;
                grid.appendChild(card);
            });
        }

        function showTooltip(e, d) {
            tooltip.style.display = 'block';
            tooltip.innerHTML = `
                <div class="tt-title">${d.n}</div>
                <div class="tt-trade">IL Trade Name: ${d.trade}</div>
                
                <span class="tt-label">Mechanism of Action</span>
                <div class="tt-content">${d.mech}</div>
                
                <span class="tt-label">Indications</span>
                <div class="tt-content">${d.indications}</div>

                <span class="tt-label">PiCCO Clinical Insights</span>
                <div class="tt-picco">${d.picco}</div>
                
                <span class="tt-label">Side Effects & Contraindications</span>
                <div class="tt-content">${d.sideeffects} <br><strong>Contra:</strong> ${d.contraindications}</div>
                
                <span class="tt-label">Dosing (Adult / Peds)</span>
                <div class="tt-content"><strong>Adults:</strong> ${d.ad} <br><strong>Pediatrics:</strong> ${d.ch}</div>

                <span class="tt-label">Clinical Remarks</span>
                <div class="tt-content">${d.rem}</div>
            `;
            moveTooltip(e);
        }

        function moveTooltip(e) {
            let x = e.clientX + 20;
            let y = e.clientY + 20;
            if (x + 450 > window.innerWidth) x = e.clientX - 470;
            if (y + 500 > window.innerHeight) y = e.clientY - 520;
            tooltip.style.left = x + 'px';
            tooltip.style.top = y + 'px';
        }

        function hideTooltip() { tooltip.style.display = 'none'; }

        // –õ–æ–≥–∏–∫–∞ –ø–µ—Ä–µ–∫–ª—é—á–µ–Ω–∏—è —Ç–µ–º –∏–∑ —à–∞–±–ª–æ–Ω–∞
        const themeBtn = document.getElementById('theme-switcher');
        const sunIcon = themeBtn.querySelector('.icon-sun');
        const moonIcon = themeBtn.querySelector('.icon-moon');

        themeBtn.onclick = () => {
            document.body.classList.toggle('light-theme');
            document.body.classList.toggle('dark-theme');
            const isLight = document.body.classList.contains('light-theme');
            sunIcon.style.display = isLight ? 'none' : 'inline';
            moonIcon.style.display = isLight ? 'inline' : 'none';
        };

        // –ë—É—Ä–≥–µ—Ä –º–µ–Ω—é
        document.getElementById('menu-toggle').onclick = function() {
            document.getElementById('main-nav').classList.toggle('active');
        };

        init();
    </script>
</body>
</html>
